A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy

Abroad (travel likely)RecruitingPHASE3

Conditions

Non-Proliferative Diabetic Retinopathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Cumberland Valley Retina Consultants, Hagerstown, Maryland, United States
Contact: Study coordinator (Allen Hu, MD) · clinicalaffairs@ocutx.com · 7813574000

Study leads

Allen Hu, MD
Principal Investigator
Cumberland Valley Retina Consultants

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema

Diabetic Retinopathy

Abroad (travel likely)RecruitingPHASE2, PHASE3

Phoenix, United States · Mountain View, United States

Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy

Non-Proliferative Diabetic Retinopathy

Abroad (travel likely)RecruitingPHASE3

Xuancheng, China · Beijing, China

Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation

Non-proliferative Diabetic Retinopathy (NPDR) · Open-angle Glaucoma (OAG) · Normal Tension Glaucoma (NTG)

Abroad (travel likely)RecruitingPHASE2

Palo Alto, United States

Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion

Non-Proliferative Diabetic Retinopathy · Retinal Vein Occlusion

Abroad (travel likely)RecruitingPHASE2

London, United Kingdom